In vivo dendritic cell reprogramming for cancer immunotherapy

Immunotherapy can lead to long-term survival for some cancer patients, yet generalized success has been hampered by insufficient antigen presentation and exclusion of immunogenic cells from the tumor microenvironment. Here, we developed an approach to reprogram tumor cells in vivo by adenoviral deli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Science
Main Authors: Ascic, Ervin, Åkerström, Fritiof, Nair, Malavika Sreekumar, Rosa, André, Kurochkin, Ilia, Zimmermannova, Olga, Catena, Xavier, Rotankova, Nadezhda, Veser, Charlotte, Rudnik, Michal, Ballocci, Tommaso, Schärer, Tiffany, Huang, Xiaoli, de Rosa Torres, Maria, Renaud, Emilie, Santiago, Marta Velasco, Met, Özcan, Askmyr, David, Lindstedt, Malin, Greiff, Lennart, Ligeon, Laure-Anne, Agarkova, Irina, Svane, Inge Marie, Pires, Cristiana F., Rosa, Fábio F., Pereira, Carlos-Filipe
Formato: Artigo
Idioma:Inglês
Publicado em: 2024
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616765/
https://ncbi.nlm.nih.gov/pubmed/39236156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.adn9083
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados